Our mother Susan has recently lost an 8 year battle with Multiple Myeloma. Please help us to honor her while making a difference in myeloma research.

Susan was a very loving and generous wife, mother, grandmother, sister, aunt, and friend. Her sense of humor and warm smile made people instantly love her. Susan was an unconditional friend; once you became friends, you were friends for life. She was still great friends with girls she met in grade school. Susan put a lot of love into bargain shopping and was determined to find the most thoughtful gift for family and friends. Susan would often be found lounging in the sun and floating in a pool. Her favorite vacation spots were somewhere warm with a beach. Susan enjoyed hosting parties and would use her amazing baking skills to make delicious treats that everyone enjoyed. The treat most of her family and friends favored was her homemade toffee. She was the best Grandma and cherished the snuggles with her granddaughter, Lila.

The Multiple Myeloma Research Foundation (MMRF), along with its research and medical industry partners, has fueled more studies, initiated more trials, developed more treatments, introduced more medicines, and have had a far greater impact than any other organization on myeloma. While the MMRF has made enormous progress, they still have much to do and cannot continue to do great research without your support.

Please consider joining me to fight multiple myeloma. Together we can make a difference.


About the MMRF:
A pioneer in precision medicine, the Multiple Myeloma Research Foundation (MMRF) seeks to find a cure for all multiple myeloma patients by relentlessly pursuing innovations that accelerate the development of precision treatments for cancer. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c)(3) nonprofit organization, the MMRF has created the business model around cancer—from data to analytics to the clinic. The MMRF identifies barriers and then finds the solutions to overcome them, bringing in the best partners and aligning incentives in the industry to drive better outcomes for patients. Since its inception, the organization has collected thousands of samples and tissues, opened nearly 100 trials, helped bring 11 FDA-approved therapies to market, and built CoMMpass, the single largest genomic dataset for any cancer. Today, the MMRF is building on its legacy in genomics and is expanding into immune-oncology, as the combination of these two fields will be critical to making precision medicine possible for all patients. The MMRF has raised nearly $500 million and directs nearly 90% of the total funds to research and related programs. To learn more, visit themmrf.org.